HomeMembersCommittees ▶ Committee

Funds For the Future

Chair Theodore F. Reiss, MD, MBE, ATSF Cambridge, MA
Vice Chair Linda Nici, MD Providence, RI
Committee Member Chris Blango Wilmington, DE
Committee Member - CCR Representative Don Hayes, MD, MS, MEd, ATSF Cincinnati, OH
Committee Member Greg Lund Kansas City, MO
Committee Member Gregory P. Downey, MD, ATSF, FRCP(C) Denver, CO
Committee Member John H. Hansen-Flaschen, MD, ATSF Philadelphia, PA
Committee Member Lynn M. Schnapp, MD, ATSF Madison, WI
Committee Member - PAR Representative Michele Manion, BS Minneapolis, MN
Committee Member Nicholas S. Hill, MD Boston, MA
Committee Member Richard K. Murray, MD San Francisco, CA
Committee Member Stuart Loesch, MBA Kenilworth, NJ
Staff Michelle Turenne New York, NY
Staff Ally Felix New York, NY
Staff Melinda Garcia New York, NY

The ATS Funds for the Future Committee generates charitable funding support to advance the careers of talented individuals committed to basic, clinical and translational research and training of the next generation of health professionals.

The Committee is comprised of ATS members and non-members who have an interest, commitment and/or professional experience in fundraising. Its goals are to cultivate fundraising both within and outside the Society’s membership, develop new approaches to fundraising and advance careers at all stages.

The chair of the FFF Committee is a member of the ATS Board of Directors. The work of the Committee should help move the society’s future plans forward.

Benchmarks 2020-2021:
• Refine the existing strategic plan and mission with consideration to the Society’s 125th Anniversary in 2030;
• Ensure that all funds raised are used as the donors intended;
• Increase funds and diversify the fundraising base to optimize support of innovative research, clinical practice and training;
• Collaborate with the ATS PAR to support early career professionals and in providing research grants to talented investigators aimed at growing our scientific understanding and improving the quality of life of patients;
• Develop partnerships with other philanthropic entities that can improve the fundraising abilities of the ATS;
• Working with Executive Staff, revisit the separation language from the American Lung Association and work toward either a collaborative fund-raising effort or the freedom from 20-year restrictions that prohibit public fundraising and use of the word “lung.”